|Title:||Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide|
|Abstract:||Methods for treatment of a parasitic infection of a trematode selected from the group consisting of Schistosoma such as Schistosoma mansoni, Schistosoma haematobium, Schistosoma mekongi, Schistosoma japonicum, and Schistosoma intercalatum, Fasciola such as Fasciola hepatica and Fasciola gigantica, Fasciolopsis buski, Dicrocoelium dendriticun, Heterophyes heterophyes, and Metagonimus yokogawa, the methods comprising administration of a pharmaceutical composition containing as active agent at least one compound selected the group consisting of a compound of formula I: ##STR1## and a compound of formula II: ##STR2##|
|Inventor(s):||Rossignol; Jean-Francois (Clearwater, FL)|
|Assignee:||Romark Laboratories, L.C. (Tampa, FL)|
Patent Claim Types:|
see list of patent claims
Field: Not categorized
Back Citations: 1st percentile
Forward Citations: 0th percentile
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||1103||► subscribe|
|African Regional IP Organization (ARIPO)||645||► subscribe|
|African Regional IP Organization (ARIPO)||9600866||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.